Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0312 | 0.0047 | 0.1478 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.249 | 0.3232 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0496 | 0.0316 | 0.0978 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0496 | 0.0316 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0496 | 0.0316 | 0.0316 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0496 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0496 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0496 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0496 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0312 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0496 | 0.0316 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0496 | 0.0316 | 0.0316 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0496 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0312 | 0.0047 | 0.1478 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0496 | 0.0316 | 0.0316 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0496 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0496 | 0.0316 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0496 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0496 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0496 | 0.0316 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0312 | 0.0047 | 0.1478 |
Giardia lamblia | GTOR | 0.0496 | 0.0316 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.7119 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0312 | 0.0047 | 0.1478 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0496 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0496 | 0.0316 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0496 | 0.0316 | 1 |
Leishmania major | hypothetical protein, conserved | 0.2585 | 0.3371 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1.2 nM | In vitro binding affinity for the melanoma receptor was determined in the murine melanoma B16/F1 cell line | ChEMBL. | 12086490 |
ID/g (functional) | = 0.01 % | Radioactivity uptake in the blood was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.027 % | Radioactivity uptake in the pancreas was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.031 % | Radioactivity uptake in the muscle was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.034 % | Radioactivity uptake in the blood was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.043 % | Radioactivity uptake in the pancreas was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.047 % | Radioactivity uptake in the muscle was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.048 % | Radioactivity uptake in the pancreas was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.06 % | Radioactivity uptake in the lungs was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.065 % | Radioactivity uptake in the blood was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.066 % | Radioactivity uptake in the heart was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.09 % | Radioactivity uptake in the spleen was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.093 % | Radioactivity uptake in the muscle was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.11 % | Radioactivity uptake in the lungs was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.12 % | Radioactivity uptake in the heart was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.13 % | Radioactivity uptake in the heart was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.14 % | Radioactivity uptake in the spleen was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.16 % | Radioactivity uptake in the liver was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.18 % | Radioactivity uptake in the lungs was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.2 % | Radioactivity uptake in the liver was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.22 % | Radioactivity uptake in the spleen was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.23 % | Radioactivity uptake in the liver was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.42 % | Radioactivity uptake in the muscle was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.59 % | Radioactivity uptake in the liver was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.59 % | Radioactivity uptake in the spleen was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.62 % | Radioactivity uptake in the pancreas was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 0.72 % | Radioactivity uptake in the heart was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 1.57 % | Radioactivity uptake in the blood was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 1.7 % | Radioactivity uptake in the lungs was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 4.86 % | Radioactivity uptake in the tumor was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 5.64 % | Radioactivity uptake in the kidneys was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
ID/g (functional) | = 8.98 % | Radioactivity uptake in the kidneys was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 9.27 % | Radioactivity uptake in the kidneys was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 9.46 % | Radioactivity uptake in the tumor was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
ID/g (functional) | = 10.36 % | Radioactivity uptake in the tumor was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
ID/g (functional) | = 11.45 % | Radioactivity uptake in the tumor was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
ID/g (functional) | = 13 % | Radioactivity uptake in the kidneys was expressed as a percentage of the injected radioactive dose per gram of tissue (% ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 0.85 | Uptake Ratio of Tumor/kidneys (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 0.88 | Uptake Ratio of Tumor/kidneys (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 1.1 | Uptake Ratio of Tumor/kidneys (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 1.3 | Uptake Ratio of Tumor/kidneys (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 6.6 | Uptake Ratio of Tumor/lungs (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 6.9 | Uptake Ratio of Tumor/blood (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 18.4 | Uptake Ratio of Tumor/liver (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 27.8 | Uptake Ratio of Tumor/muscle (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 0.5 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 32.7 | Uptake Ratio of Tumor/liver (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 49.4 | Uptake Ratio of Tumor/liver (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 49.9 | Uptake Ratio of Tumor/liver (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 69.4 | Uptake Ratio of Tumor/lungs (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 100.3 | Uptake Ratio of Tumor/lungs (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 159.3 | Uptake Ratio of Tumor/muscle (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 168.6 | Uptake Ratio of Tumor/lungs (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 173.2 | Uptake Ratio of Tumor/muscle (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 196.4 | Uptake Ratio of Tumor/blood (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 318.9 | Uptake Ratio of Tumor/muscle (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 2 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 489.8 | Uptake Ratio of Tumor/blood (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 4 h | ChEMBL. | 12086490 |
Uptake ratio (functional) | = 601 | Uptake Ratio of Tumor/blood (each in % ID/g) in B16/F1 Murine Melanoma-Bearing C57 Mice at 24 h | ChEMBL. | 12086490 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.